Select Page

Webinars and Podcasts

Hemostatic Efficacy of Pathogen Reduced Platelets in Pediatric Cardiopulmonary Bypass

Leading US hospitals1 are implementing PR platelets to ensure platelet availability and safety across a broad spectrum of pathogens. Doctor Marianne Nellis of Cornell shares study findings that assess PR platelet hemostatic efficacy via bleeding in pediatric patients.

Marianne E. Nellis, MD, MS
Pediatrician/Attending Physician
Division of Pediatric Critical Care Medicine

Department of Pediatrics
Weill Cornell Medicine

  1. U.S. News & World Report Hospital Rankings & Ratings, 2020-2021,

Watch the Replay
Runtime: 20 min